Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: sodium hydroxide; hydrochloric acid - palliation and treatment adjuvant to surgery and radiation therapy of the following neoplasms: squamous cell carcinoma of the skin, head and neck, and oesophagus (primary indication). squamous cell carcinoma of the larynx, penis and uterine cervix. squamous cell carcinoma of the bronchus (response infrequent). choriocarcinoma and embryonal cell carcinoma of the testis. advanced hodgkin's disease and other lymphomas. mycosis fungoides note. use of bleomycin after radiation therapy is less successful than use before radiation therapy. bleomycin is bone marrow sparing and may be used when other cytotoxic agents are contraindicated.

Canada - English - Health Canada

pfizer canada ulc - bleomycin (bleomycin sulfate) - powder for solution - 15unit - bleomycin (bleomycin sulfate) 15unit - antineoplastic agents

Canada - English - Health Canada

fresenius kabi canada ltd - bleomycin (bleomycin sulfate) - powder for solution - 15unit - bleomycin (bleomycin sulfate) 15unit - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - palliation and treatment adjuvant to surgery and radiation therapy of the following neoplasms: = squamous cell carcinoma of the skin, head and neck, and oesophagus (primary indication). = squamous cell carcinoma of the larynx, penis and uterine cervix. = squamous cell carcinoma of the bronchus (response infrequent). = choriocarcinoma and embryonal cell carcinoma of the testis. = advanced hodgkin's disease and other lymphomas. = mycosis fungoides.,note. use of bleomycin after radiation therapy is less successful than use before radiation therapy. bleomycin is bone marrow sparing and may be used when other cytotoxic agents are contraindicated.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - bleomycin sulfate 15000 [iu];   - powder for injection - 15000 iu - active: bleomycin sulfate 15000 [iu]   excipient: water for injection - dbl™ bleomycin sulfate for injection should be considered a palliative treatment. it has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents; squamous cell carcinoma: head and neck including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingiva, epiglottis, skin, larynx, penis, cervix, and vulva. the response to bleomycin sulfate is poorer in patients with head and neck cancer previously irradiated.

Ireland - English - HPRA (Health Products Regulatory Authority)

leo pharma a/s - sodium fusidate - impregnated dressing - 30 milligram(s) - medicated dressings with antiinfectives; fusidic acid - medicated dressings with antiinfectives - fucidin is indicated for the treatment of skin infections caused by bacteria susceptible to sodium fusidate in children from 1 year of age and adults. consideration should be given to official guidance on the appropriate use of antibacterial agents. prescribers should consider local resistance and susceptibility.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: - bleomycin is used for palliation and/or treatment adjuvant to surgery and radiation therapy and in the management of the following neoplasms: squamous cell carcinoma of the skin, head and neck, and oesophagus is the primary indication for bleomycin. tumour response has been obained in a number of patients with squamous cell carcinoma of the penis, larynx and uterine cervix. infrequent response has been shown in squamous cell carcinoma of the bronchus. treatment of choriocarcinoma and embryonal cell carcinoma of the testis is also indicated. bleomycin has been effectively used in advanced hodgkin's disease and in some cases of other lymphomas such as non-hodgkin's, and also in cases of mycosis fungoides.

Malta - English - Malta Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - bleomycin sulfate - powder for solution for injection - bleomycin sulfate 1,500 iu/ml - antineoplastic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmachemie bv - bleomycin sulfate - pdr for soln for injection - 15 u (usp)/vial %v/v

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira uk ltd - bleomycin sulfate - unknown - 15000iu/vi %v/v